XML 57 R32.htm IDEA: XBRL DOCUMENT v3.19.1

Merger with Mirna Therapeutics (Tables)

12 Months Ended

Dec. 31, 2018

Business Combinations [Abstract]

Net Assets Acquired in the Merger

The following table shows the net assets acquired in the Merger (in thousands):

		August 28, 2017
Cash and cash equivalents		$	14,882
Marketable securities			27,600
Interest receivable			126
Prepaid assets			112
Unrealized loss on marketable securities			5
Accounts payable and accrued expenses			(105	)
Total net assets acquired			42,620
Less: Transaction costs			(2,187	)
Total net assets acquired less transaction costs		$	40,433

X

- References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration